Phathom Pharmaceuticals, Inc. PHAT Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$221.25M+33.8% | -$334.33M-65.8% | -$201.59M-2.0% | -$197.72M-37.4% | ||
| $633K-20.4% | $795K+38.3% | $575K-7.3% | $620K+19.0% | ||
| $28.72M+19.4% | $24.05M-46.6% | $45.03M+86.6% | $24.13M+43.5% | ||
| $3.01M+37.5% | $2.19M+16.8% | $1.88M-11.0% | $2.11M-41.3% | ||
| $39.33M+5.8% | $37.16M+2,170% | $1.64M— | $0— | ||
| —— | $6.41M-32.1% | $9.44M— | $0— | ||
| $34.1M-2.4% | $34.94M— | —— | $8.68M— | ||
| $1.22M— | $0— | —— | —— | ||
| -$5.21M-2.1% | -$5.1M-173% | -$1.87M-40.6% | -$1.33M-61.5% | ||
| —— | —— | —— | —— | ||
| -$166.78M+37.5% | -$266.77M-93.9% | -$137.58M+6.1% | -$146.53M+1.3% | ||
| $229K+69.6% | $135K-91.7% | $1.63M+57.0% | $1.04M+217% | ||
| -$229K-69.6% | -$135K+91.7% | -$1.63M-57.0% | -$1.04M-217% | ||
| $0-100% | $59.4M+51.1% | $39.32M— | $0-100% | ||
| —— | —— | —— | —— | ||
| $1.64M— | —— | $14.07M— | $0-100% | ||
| -$288K-100% | $182.77M-50.3% | $367.58M— | —— | ||
| -$167.29M— | —— | —— | -$27.53M— | ||
| $21.37M+23.6% | $17.29M+55.3% | $11.13M+58.3% | $7.03M+72.8% | ||
| —— | $46.11M— | —— | —— | ||
| $3.01M+37.5% | $2.19M+16.8% | $1.88M-11.0% | $2.11M-41.3% | ||
| —— | $565K+93.5% | $292K-22.5% | $377K+128% | ||
| $222K+26.9% | $175K-9.8% | $194K— | —— | ||
| —— | $8.19M— | —— | $1.86M— | ||
| —— | $836K— | —— | —— | ||
| -$5.21M-2.1% | -$5.1M-173% | -$1.87M-40.6% | -$1.33M-61.5% | ||
| —— | $0— | —— | —— | ||
| —— | —— | $141.39M— | $0— | ||
| $0-100% | $8K— | —— | —— | ||
| $0— | —— | —— | $0-100% | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| -$167M+37.4% | -$266.91M-91.7% | -$139.21M+5.7% | -$147.57M+0.8% | ||
| -$167M+37.4% | -$266.91M-91.7% | -$139.21M+5.7% | -$147.57M+0.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Phathom Pharmaceuticals, Inc. generate?
- Phathom Pharmaceuticals, Inc. (PHAT) generated -$97.5M in operating cash flow over the trailing twelve months.
- What is Phathom Pharmaceuticals, Inc.'s free cash flow?
- After $272.0K of capital expenditures, Phathom Pharmaceuticals, Inc.'s free cash flow was -$97.8M over the trailing twelve months, up 65.4% year over year.
- Where does Phathom Pharmaceuticals, Inc.'s cash flow data come from?
- Every line is extracted from Phathom Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
